Bridging MedTech Innovation to Market Adoption

Singapore Clinical Research Institute (SCRI), National Health Innovation Centre (NHIC) and MedTech Catapult (MC) will collaborate in a partnership to catalyse synergy across the MedTech ecosystem and strengthen clinical adoption support for early-stage innovators and academic spinoffs.

📅 Date: 25 August 2025 (Monday)

🕘 Time: 16:00 – 18:00 hrs (Registration starts at 15:30 hrs)

Please write in to biz@scri.cris.sg if keen to register for this event.

HIGHLIGHTS

•👤👤 MOU between National Health Innovation Centre Singapore (NHIC), Singapore Clinical Research Institute (SCRI) and MedTech Catapult (MC), a national initiative hosted by the Agency for Science, Technology and Research (A*STAR).

• 👤 Featured Talk: “Regulatory Framework for Artificial Intelligence enabled Medical Devices” by Ms Koh Kah Leng, Senior Regulatory Specialist, Health Sciences Authority (HSA)

Background

Artificial intelligence (AI) is rapidly transforming the medical device sector, with the US Food and Drug Administration (FDA) authorising over 1,000 AI-enabled devices in total as of August 2024. There has been a dramatic rise from just six approvals in 2015 to 235 in 2024.

Singapore, as a regional hub for MedTech innovation, is also experiencing growth in this space, driven by a vibrant ecosystem of startups, academic spin-offs, and industry leaders. As AI-powered solutions become more prevalent, the path to successful adoption hinges on robust clinical usability studies, formative research, and comprehensive clinical trial data. These elements are essential to demonstrate real-world value and ensure patient safety.  

As part of the programme, Ms Koh Kah Leng, Senior Regulatory Specialist, Health Sciences Authority (HSA) will present on the evolving regulatory framework for AI-enabled medical devices, highlighting how updated guidelines and a lifecycle regulatory approach will support the next wave of MedTech innovation and adoption.  

Who should attend

This is an event to gain clarity on early engagement with regulators for novel devices and network with key stakeholders from industry, academia, and government agencies—all working together to advance healthcare. We look forward to supporting MedTechs’ journey from bench to bedside.

Brought to you by

NHIC and SCRI is a business unit of the Consortium for Clinical Research and Innovation, Singapore (CRIS).